510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0006-2017Class I

HeartWare Ventricular Assist System (HVAD), US product: Model No.: 1103; and International Product: Model...

HeartWare, Inc. / initiated 2016-08-17 / Open, Classified / root cause: design

HeartWare, Inc began a recall of HeartWare Ventricular Assist System (HVAD), US product: Model No.: 1103; and International Product: Model No.: 1104XX. Product Usage: For use as a... on . FDA classified it as Class I and gives the reason as "Foreign material found within the driveline connector of the HVAD Pump that could cause increased impedance resulting in electrical faults". As of , the recall status on record is Open, Classified, and MDM tags the root cause as design.

Recall record

Recall number
Z-0006-2017
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
HeartWare, Inc.
Product
HeartWare Ventricular Assist System (HVAD), US product: Model No.: 1103; and International Product: Model No.: 1104XX. Product Usage: For use as a bridge-to-cardiac transplantation in patients who are at risk of death from refractory end-stage left ventricular heart failure. Designed for in-hospital and out-of-hospital settings, including transportation via fix-wing aircraft or helicopter.
Product code
DSQ Ventricular (Assist) Bypass
Reason for recall
Foreign material found within the driveline connector of the HVAD Pump that could cause increased impedance resulting in electrical faults.
Root cause tag
design
FDA root cause
Component design/selection
Action
HeartWare notified their customers with an Urgent Medical Device Recall notice on 8/17/2016 of the HVAD Pump, listing the US Product: Model No. 1103 and the International Product: Model No.: 1104. The letter discussed the reason for the recall as well as the risk to health. Customers were to identify affected product in their inventory; and, complete and return the acknowledgement form. Acknowledgement should be provided no later than 30 days from date of the letter either to the HeartWare representative; or, via e-mail to FSCA @Heartware.com; or, FAX the signed form to (305) 364-2665. Affected product should be returned upon receipt of replacement product; and, the completion form should also be completed and returned. Questions or concerns should be directed to a local HeartWare representative.
Quantity in commerce
344 pumps
Distribution
Worldwide Distribution - US, in the states of AL, AR, AZ, CA, DC, FL, IL, IN, KY, LA, MA, MI, MN, MO, NC, NE, NJ, NY, OH, OK, PA, SC, TX, UT, VA, and WI; and, the countries of Argentina, Belarus, Bosnia, Herzegovina, Brazil, Canada, Chile, Colombia, Hong Kong, India, Israel, Kazakhstan, Kuwait, Lebanon, Malaysia, New Zealand, Saudi Arabia, Serbia, Singapore, South Africa, South Korea, Taiwan, Turkey, and Vietnam.
Product codes and lots
All sterile un-implanted stock manufactured prior to HW25838 is subject to removal.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0006-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0006-2017Class IOngoingVoluntary: Firm initiated